Use of Tl-201 over Tc-99m linked to higher costs, future testing

08/5/2013 | CardiovascularBusiness.com

A study published in the journal Circulation: Cardiovascular Imaging found that switching from isotope technetium-99m to thallium-201 may raise long-term costs, testing and radiation dose. Researchers at the University of Ottawa Heart Institute collected data from 7,402 consecutive patients who underwent SPECT MPI before, during and after the institute's substitution of Tl-201 during a shortage of Tc-99m. False positives were higher with Tl-201, and the isotope "was associated with a significant increase (9.8%) in downstream resource utilization amounting to a cost increase of $74.25/patient," researchers said.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX